DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Lv XY, Ding HG, Zheng JF, Fan CL, Li L.
Rifaximin improves survival in cirrhotic patients with refractory ascites: a real-world study.
World J Gastroenterol 2020;
26 (02) 199-218
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.